Stock search

Ticker or company name

Compare stocks

Market: US

  • ELVElevance Health
  • HCAHCA Healthcare
  • CICigna

Add stock

Ticker or company

Summary

ELV
Elevance Health
$446,28Up +3,86%
Year: Up +31%
78/100Ratio would consider buying
Open stock page
HCA
HCA Healthcare
$511,78Up +2,55%
Year: Up +5%
69/100Ratio would watch
Open stock page
CI
Cigna
$300,16Up +1,06%
Year: Up +10%
89/100Best scoreRatio would consider buying
Open stock page

Verdict

CI has the best score (89). CI grows revenue the fastest. CI is the cheapest by forward P/E. ELV has the lowest debt load. HCA has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckELV6 ✓ 2 — 1 ✕HCA4 ✓ 3 — 1 ✕CI7 ✓ 2 — 0 ✕
P/E vs its history18,115,413,1
P/E vs industry18,115,413,1
Forward P/E14,015,29,1
Revenue growth, YoY+3,6%+5,8%+6,8%
EPS growth, YoY−4,1%+16,5%+0,3%
Net margin2,5%8,6%2,3%
Net debt / EBITDA−0,8n/a—−0,6
Free cash flow$6,51 bn$5,97 bn$9,43 bn
Share count over a year−2,7%−8,0%−1,4%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterELVTTMHCATTMCITTMIndustry medianTTM
P/E TTM ↓Worst: 18,115,4Best: 13,125,1
Forward P/E ↓14,0Worst: 15,2Best: 9,116,2
PEG ↓Worst: 4,01,8Best: 1,42,2
P/S TTM ↓0,5Worst: 1,3Best: 0,32,2
EV/EBITDA ↓Worst: 13,89,7Best: 8,917,3
P/FCF ↓13,8Worst: 17,5Best: 8,719,5

Price, %

  • ELVn/a
  • HCAn/a
  • CIn/a

Returns

Best WorstNo mark — in between

PeriodELVHCACI
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

ELVHCACI
Share of “buy”68%Worst: 58%Best: 74%
Beat the forecastBest: 4 of 43 of 4Worst: 1 of 4
Average “surprise”Best: +22,1%+4,1%Worst: +0,4%
Insiders over 12 monthssales $4,74 msales $47,5 msales $66,8 m

Details are on each stock page.